Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis

Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis

The real-world benefits of direct-acting antiviral (DAA)-induced sustained virologic response (SVR) on the de novo occurrence and progression of esophageal varices (EV) remain unclear in patients with hepatitis C virus (HCV)-related liver cirrhosis (LC). This is a retrospective cohort study evaluati...

Full description

Bibliographic Details
Main Authors: Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Viruses
Subjects:
liver cirrhosis
esophageal varices
portal hypertension
direct-acting antiviral
sustained virologic response
Online Access:https://www.mdpi.com/1999-4915/15/1/252

Internet

https://www.mdpi.com/1999-4915/15/1/252

Similar Items